Cargando…
Targeting β(3)-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade
Cardiac diseases, such as heart failure, remain leading causes of morbidity and mortality worldwide, with myocardial infarction as the most common etiology. HF is characterized by β-adrenergic receptor (βAR) dysregulation that is primarily due to the upregulation of G protein–coupled receptor kinase...
Autores principales: | Cannavo, Alessandro, Koch, Walter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295490/ https://www.ncbi.nlm.nih.gov/pubmed/28170359 http://dx.doi.org/10.1097/FJC.0000000000000444 |
Ejemplares similares
-
Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014) -
Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018) -
Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018) -
FDA review times for new drugs in ophthalmology
por: Carpenter, Michelle A., et al.
Publicado: (2020) -
Five variables that rule your life – Home mortgage and biostatistical power
por: Novack, Gary D.
Publicado: (2020)